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Endothelin (ET) is a potent vasoconstrictor that is now known
to modulate kidney tubule transport, including kidney tubule
acidification. Animals undergoing an acid challenge to
systemic acid–base status and with some models of chronic
metabolic acidosis have increased kidney ET production.
Increased ET production/activity contributes to enhanced
kidney tubule acidification that facilitates kidney acid
excretion in response to an acid challenge to systemic
acid–base status. The data to date support a physiologic role
for ET in mediating enhanced kidney acidification in response
to acid challenges, but do not support an ET role in
maintaining kidney tubule acidification in control, non-acid-
challenged states. ET increases acidification in both the
proximal and distal nephron and appears to exert its effects
both directly and indirectly, the latter through modulating
the levels and/or activity or other mediators of kidney tubule
acidification. ET also contributes to enhanced kidney
acidification in some pathophysiologic states and might
contribute to some untoward outcomes associated with
these conditions. Whether ET should be a therapeutic target
in treating and/or preventing some of these untoward
outcomes remains an open question. This review supports
continued research into the physiologic and possibly
pathophysiologic role of ET in settings of increased kidney
tubule acidification.
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Enhanced net acid excretion by the kidney contributes to
correcting the disturbance in systemic acid–base status
induced by an acid challenge.1,2 Because a systemic acid
challenge increases kidney endothelin (ET) activity3,4 and ET
increases acidification in kidney tissue in vitro,5,6 investiga-
tors have explored a possible physiologic role for ET in
mediating kidney acidification. Investigations to date support
an important physiologic role for ET in mediating enhanced
kidney acidification in response to an acid challenge to
systemic acid–base status. The data suggest that ET also
contributes to increased kidney acidification observed in
pathophysiologic states like chronic metabolic alkalosis7 and
chronic kidney disease (CKD).8 Improved understanding of
the cascade of factors that contribute to enhanced kidney
acidification in response to an acid challenge and how these
factors lead to increased acidification will help design better
management strategies for disturbances of acid–base balance.
This understanding will also enhance our understanding of
pathologic changes associated with pathophysiologic states of
chronically increased kidney acidification like CKD to which
increased ET activity might contribute.
OVERVIEW OF ET BIOLOGY
ETs are a family of 21 amino-acid peptides, known best as
powerful vasoconstrictors. ET-1 is the major isoform of those
described (ET-1, ET-2, and ET-3) and is the only one
expressed as a protein in human kidneys.9 Its production is
regulated at the level of transcription in ET-producing tissues
examined, including kidney microvascular endothelium.10
Unlike other vasoactive substances, ET does not accumulate
in secretory granules but is synthesized and released
constitutively and/or in response to a stimulus.11 The initial
gene product is the 212 amino-acid peptide pre-pro-ET-1
that is converted to a 38 amino-acid peptide called big ET-1
by ET-converting enzyme.12 Although many enzymes convert
big ET-1 to ET-1, the enzymes that mostly do so at
physiologic pH (pH optimum¼ 7.0) are the family of neutral
metalloproteinases.13 In turn, this locally produced ET-1 is
degraded by neutral endopeptidase.14,15 It follows that ET
activity might be modified by local synthesis and/or
degradation. Indeed, many tissues have both the synthetic
and degradation machinery for ET-1 including kidneys,16
suggesting local production and degradation of ET-1 that
modulates tissue function in an autocrine/paracrine manner
(see below).
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ET has long been recognized as a potent vasoconstrictor,12
with the kidney vasculature being particularly sensitive to its
vasoconstrictor effects in animals17 and humans.18 In
addition to its effects on kidney vasculature, ET also
influences kidney tubule function. ET-1 inhibits vasopres-
sin-stimulated water transport in the kidney collecting
duct.19 Furthermore, low ET-1 levels inhibit the amiloride-
sensitive, epithelial sodium channel through ET-B recep-
tors20,21 but higher levels stimulate it, presumably through
ET-A receptors.20 These in vitro data are complemented by in
vivo studies showing that low doses of exogenous ET-1
induce diuresis and natriuresis.22 Regarding its effects on
acid–base transport, ET increases proton (Hþ ) secretion in
the proximal1 and distal3 nephron and decreases HCO3
secretion in the distal nephron.23–25 Exogenous ET adminis-
tered in vivo increases distal nephron acidification through
increased Hþ secretion and decreased HCO3 secretion.
25
OVERVIEW OF THE KIDNEY RESPONSE TO ACID–BASE
CHALLENGES
Because altered systemic acid–base homeostasis adversely
affects cell function, multiple systems including lung, liver,
bone, gut, and of course, kidneys coordinate to help maintain
body fluid hydrogen ion concentration ([Hþ ]) within range
for optimal cell function. For most humans, the major and
routine acid challenge to systemic acid–base homeostasis is
acid derived from liver metabolism of dietary protein.26
Metabolism of sulfur- and phosphate-containing amino acids
yields Hþ , metabolism of dicarboxylic amino acids con-
sumes Hþ , and metabolism of neutral amino acids yields
neither production nor consumption of Hþ . Diets in most
Western industrialized societies include sulfur-containing
animal protein, which when metabolized by the liver yields
acid, classically at a rate of about 1 mmole Hþ /kg bw daily.26
Acid challenges also increase organic acid production that
additionally challenges systemic acid–base status with Hþ
that must be excreted to restore acid–base balance toward the
optimal range.27 Metabolically produced Hþ might increase
body fluid [Hþ ] and induce a physiologic response designed
to return [Hþ ] toward the optimum. Two responses
intended to maintain and/or restore optimal range of body
fluid [Hþ ] are (1) Hþ buffering,28 in which body buffers
bind added Hþ to minimize the [Hþ ] increase that would
otherwise occur, and (2) Hþ excretion26 in which Hþ is
removed from the body. Because Hþ -titrated buffers less
effectively buffer subsequently added Hþ , buffer-bound Hþ
must eventually be excreted to regenerate body buffers and
restore buffering capacity. Consequently, all added Hþ must
be excreted to restore acid–base homeostasis to baseline.
Steady-state net Hþ excretion in man is equivalent to net
Hþ production and the kidney is the major route of fixed
Hþ excretion.26,27 ET-mediated acidification contributes to
the kidney response to an acid challenge, but does not
mediate kidney acidification under control conditions.3,29,30
Accordingly, this brief overview of kidney acid–base physio-
logy will focus on the kidney response to an acid challenge
rather than on steady-state acidification so as to help put into
perspective the role that ET plays in kidney acidification.
Most experimental models exploring the effect of an acid
challenge to systemic acid–base status have used acid
challenges that are in excess of that routinely encountered
by animals or humans. This experimentally induced acid
challenge is typically performed by intravenous administra-
tion and/or voluntary intake plus gavage feeding of mineral
acid to induce metabolic acidosis indicated by measurable
changes in plasma acid–base parameters.31 Such studies show
an important role for enhanced proximal tubule acidification
in mediating kidney excretion of administered acid.31 The
Naþ /Hþ exchanger (NHE) type 3 is the major luminal Hþ
transporter in the proximal tubule with more modest
contributions by Hþ -ATPase.32 These large acid loads lead
to increased activity of both NHE type 332 and Hþ -ATPase33
in the proximal tubule. Similarly, these large acid loads
increase acidification in the thick ascending limb of the loop
of Henle.34 Because NHE is the major luminal Hþ
transporter in this nephron segment with smaller contribu-
tions by Hþ -ATPase,34 the acidification increase in response
to this acid challenge presumably includes stimulated NHE
activity. Finally, these large acid loads administered systemi-
cally enhance distal nephron acidification35–37 that is
mediated by enhanced activity of NHE,37 Hþ -ATPase,38
and Hþ , Kþ -ATPase.39 In short, large acid loads adminis-
tered systemically lead to increased acidification in most
acidifying nephron segments that have been studied.
Animals and humans rarely face acid challenges of the
magnitude used in most experimental models. The more
routine acid challenge faced by humans is much more
modest and is associated with little to no measurable changes
in plasma acid–base parameters.40 When NH4Cl is adminis-
tered chronically to provide a more modest acid challenge
that substantially increases urine net acid excretion (NAE)
without measurable changes in plasma acid–base parameters
or single nephron glomerular filtration rate, distal nephron
acidification increases without measurable changes in
proximal nephron acidification.2,3,41 The data support that
modest challenges to systemic acid–base status induce a
greater proportional increase in distal than proximal nephron
acidification compared to the respective steady state.
Furthermore, the acid challenge faced by humans is not
typically provided by mineral salts, but instead by Hþ -
producing dietary protein. Increased Hþ -producing dietary
protein increases distal nephron acidification23,30,42,43 that is
clearly evident with comparable HCO3-delivered loads.
30
Enhanced distal nephron acidification in response to a more
physiologic acid challenge is mediated by both decreased
HCO3 secretion and increased H
þ secretion, whether the
challenge is induced by modest NH4Cl ingestion
2,3 or
increased intake of Hþ -producing dietary protein.23,30,43
Increased intake of Hþ -producing dietary protein also
increases proximal tubule acidification, as indicated by
overall recovery of increased filtered HCO3 load mediated
by increased whole kidney and single nephron glomerular
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filtration rate induced by high protein diet.23 Whether
increased proximal tubule HCO3 reabsorption in animals
with increased dietary protein intake is entirely due to
response to flow-dependent increase in HCO3-delivered
load44 and/or is increased at comparable HCO3-delivered
loads awaits further study.
The data showing that modest and/or more physiologic acid
challenges to systemic acid–base can induce dramatic changes
in kidney acidification with little to no measurable changes in
plasma acid–base parameters question whether mediators of a
sustained increase in kidney acidification require sustained
changes in these plasma parameters. Alternatively, other
‘sensors’, possibly intracellular, might be sufficient to maintain
the necessary cascade of responses to sustain increased kidney
acidification. In vitro studies show that intracellular pH of
cultured kidney epithelial cells chronically (48 h) exposed to
acid media was not different from control, yet these cells had
increased Naþ /Hþ antiporter activity.45 In vivo studies show
that a chronic dietary acid challenge that increases kidney NAE
and distal nephron acidification without measurable changes
in plasma acid–base parameters nevertheless increases Hþ
content of the kidney interstitium,41 a communicating space
between vascular endothelium and tubule epithelium.46 The
data suggest that persistent, measurable alterations in plasma
or intracellular fluid acid–base parameters are not necessary to
permit a sustained increase in kidney tubule acidification.
These data raise the possibility that parameters of increased
body Hþ content other than plasma or intracellular acid–base
parameters serve as sensors that lead to enhanced kidney
acidification. Possible ‘acid sensors’ include activated intra-
cellular systems like c-steroid receptor coactivator and
extracellular signal-regulated protein kinase47 and Pyk2.48
Activation of these intracellular systems leads to ET-mediated
upregulation of Naþ /Hþ exchange in proximal tubule
epithelia in vitro.47,48 Alternatively, these and other kinases
might work downstream of ET to mediate ET-B signal
transduction. Consequently, acid challenges might increase
kidney acidification through altered intracellular systems that
increase production of substances that directly/indirectly
influence kidney acidification. ET activity might be increased
in this way.
ET PRODUCTION BY VASCULAR ENDOTHELIUM
ET production by human vascular endothelium occurs in
arterial macrovascular,49,50 arterial microvascular,10,50 and
venous51,52 endothelium. Secretion of ET from vascular
endothelial cells is predominately toward their basolateral
surfaces,51 suggesting paracrine modulation by ET in tissues
with which vasculature is associated as suggested earlier.
There is also evidence for autocrine regulation of cellular ET
secretion by vascular endothelium.53
ET PRODUCTION BY KIDNEY PARENCHYMA AND ITS
POSSIBLE PHYSIOLOGIC ROLE
In addition to previously stated ET production by
microvascular endothelium,10 mesangial54 and glomerular
epithelial cells55 produce and secrete ET. Kidney tubule
epithelia that produce/secrete ET in vitro include proximal
tubule,56 medullary thick ascending limb,57 distal tubule,58
cortical collecting tubule,59 and inner medullary collecting
duct60 with the greatest amount from the latter.57 Kidney
tubule epithelia have ET receptors, mostly of the B subtype,61
located predominantly on their basolateral surfaces.62 Also,
the kidney has a system for local ET degradation,14,16
consistent with paracrine3 and/or autocrine4 control of
kidney tubule function by locally produced ET. The intimate
anatomic relationship between kidney vasculature and
tubules,46 and the presence of ET in the interstitial space
between3 permit possible paracrine control of kidney tubule
function. This proposed cascade is supported by data
showing that dietary mineral acid3 and increased intake of
Hþ -producing dietary protein30 increase ET levels in the
kidney interstitium and induce an ET-mediated increase in
distal nephron acidification through stimulation of B-type
ET receptors.3
EFFECTS OF ACID CHALLENGE ON KIDNEY ET PRODUCTION
Acid loading with dietary ammonium salts increases kidney
mRNA ET expression,1,29 and kidney ET production.3
Similarly, increased intake of Hþ -producing dietary protein
increases expression of kidney ET mRNA and kidney ET
production.30 Although cell source(s) of this Hþ -induced
increment in kidney ET is unclear, acid extracellular
environment increases ET secretion by proximal tubule
epithelium45 and kidney microvascular endothelium10 in
vitro as stated earlier. An acid challenge to systemic acid–base
status might alter intracellular systems independent of
plasma or intracellular pH,47,48 as discussed earlier that
increase ET production/secretion by these and possibly other
kidney cell types.
ET PRODUCTION BY ADRENAL CORTEX AND ITS POSSIBLE
ROLE IN ENHANCED KIDNEY ACIDIFICATION
Acid-stimulated ET secretion from non-kidney tissue might
directly or indirectly enhance kidney acidification in response
to an acid challenge. Some studies support that ET-
stimulated aldosterone secretion63 enhances distal nephron
acidification induced by Hþ -producing dietary protein.43
Dietary mineral acid64 and Hþ -producing dietary protein43
increase plasma aldosterone. Furthermore, an acid extra-
cellular environment increases aldosterone secretion by
adrenocortical cells in vitro.65 In vivo studies discussed earlier
showed that the increment in plasma levels and urine
excretion of aldosterone induced by Hþ -producing dietary
protein was inhibited by ET receptor antagonism, supporting
that increased aldosterone secretion in this setting was
mediated, at least in part, by ET.43 The adrenal cortex
synthesizes ETs66 that stimulate secretion of mineralocorti-
coids67,68 and glucocorticoids.68 Because glucocorticoids69,70
and mineralocoriticoids71 stimulate Hþ secretion in kidney
tubule epithelium, adrenal cortical ETs might indirectly
increase kidney acidification through increased mineralo-
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corticoid and glucocorticoid secretion. Whether an acid
challenge stimulates ET secretion by adrenocortical cells is
unknown.
ET EFFECTS ON ACIDIFICATION
Cells
ET increases intracellular pH of many cell types in vitro
including skin fibroblasts,72 platelets,73 vascular smooth
muscle,74 glomerular mesangial,75 cardiac myocyte,76 and
kidney epithelial cells.77 ET increases Naþ /Hþ antiporter
activity in kidney epithelial membrane vesicles5 and cortical
slices,6 and is the cell membrane Hþ transporter that is most
consistently influenced by ET in these indicated cell types.
Kidney tubules
In addition to enhancing cell membrane Hþ transport, ET
influences acidification across kidney tubule epithelia. ET
mediates enhanced proximal tubule acidification in chronic
metabolic acidosis induced by NH4Cl loading through
stimulation of ET B-type receptors, but appears not to
mediate proximal tubule acidification in non-acid-loaded
animals.1,28 ET mediates enhanced distal nephron acidifica-
tion associated induced by dietary Hþ loading with NH4
þ
salts3 and Hþ -producing dietary protein.23,30,43 ET also
stimulates Hþ secretion in alpha-intercalated cells and
decreases HCO3 secretion in beta-intercalated cells of the
rabbit cortical collecting duct in an in vitro model of
metabolic acidosis.24 The latter studies support that these
effects of ET are direct rather than acting through other
mediators. In addition, exogenous ET stimulates distal
nephron acidification in vivo.25 As observed in the proximal
tubule, ET appears not to mediate basal distal nephron
acidification in control animals.3,30,43 In the loop of Henle,
ET stimulates local nitric oxide (NO) release78 and NO
inhibits thick ascending limb Naþ /Hþ exchange,79 suggest-
ing that ET indirectly inhibits acidification in this segment.
Because ET-induced NO action on thick ascending limb
Naþ /Hþ exchange activity might more importantly inhibit
NaCl reabsorption in this nephron segment,80 this indirect
action of ET action in the thick ascending limb would
increase distal nephron Naþ delivery with an anticipated
increase in distal nephron Naþ /Hþ exchange activity,81
enhancing distal nephron acidification. Consequently, the net
effect of ET is increased proximal and distal nephron
acidification.
DIRECT MECHANISMS BY WHICH ACID-INDUCED ET AFFECTS
KIDNEY ACIDIFICATION
ET enhances Naþ /Hþ exchange activity in many cell types
in vitro as indicated earlier, most of which express primarily
type 1 NHE isoform.82 ET increases proximal tubule
acidification in Hþ -challenged animals and cells primarily
if not exclusively through enhanced activity of the NHE type
3,1,29,83 the major Hþ transporter in the proximal tubule.32
Because ET increases Naþ /Hþ exchange in the distal tubule
and NHE type 2 appears to be the major apical NHE isoform
responsible for luminal Hþ secretion in this segment,84 ET
appears to increase NHE type 2 activity. As noted, ET
stimulates Hþ secretion in alpha-intercalated cells24 whose
luminal acidification is mediated predominantly by Hþ -
ATPase activity.85,86 These studies24 conducted in vitro
suggest that ET can stimulate Hþ -ATPase activity without
acting through other mediators. On the other hand, ET might
indirectly stimulate distal nephron Hþ -ATPase in vivo30,43
through ET-induced stimulation of aldosterone secretion,
which in turn increases distal nephron Hþ -ATPase activity.43
Whether ET stimulates Hþ -ATPase activity in vivo directly
and/or through other mediators awaits clarification.
POSSIBLE INDIRECT MECHANISMS BY WHICH ET INCREASES
KIDNEY ACIDIFICATION
Because many cytokines influence distal nephron acidifica-
tion and ET influences levels of many of these cytokines, ET
might affect kidney acidification indirectly as well as directly.
As discussed earlier, increased ET activity increases distal
nephron Hþ -ATPase activity in vivo through stimulated
aldosterone secretion.43 Of the three major distal nehron Hþ
transporters (NHE, Hþ -ATPase, and Hþ , Kþ -ATPase),87
dietary acid leads to ET-mediated stimulated activity of Naþ /
Hþ exchange1,29 and Hþ -ATPase.30,43 Dietary Hþ -induced,
ET-mediated distal nephron acidification appears not to be
mediated by stimulated Hþ , Kþ -ATPase activity.43 Although
Kþ depletion increases Hþ , Kþ -ATPase activity,7,71 stimu-
lated Hþ , Kþ -ATPase in chronic metabolic alkalosis
associated with Kþ depletion appears not to be mediated
by ET.7 In addition, ETs might indirectly enhance kidney
acidification through ET-stimulated secretion of mineralo-
corticoids and glucocorticoids by the adrenal cortex67,68 that
stimulate Hþ -ATPase71 and Naþ /Hþ exchange,69,70 respec-
tively, in kidney tubules as discussed earlier.
Reduced HCO3 secretion contributes importantly to
enhanced acidification induced by chronic dietary ingestion
of mineral acid2,3 and Hþ -producing dietary protein.23,30,43
The phenomenon of reduced HCO3 delivery to the terminal
distal nephron in and of itself increases NAE,87 but this
phenomenon also enhances NH4
þ secretion88 and permits
secreted Hþ to titrate non-HCO3 buffers and thereby
constitute NAE rather than HCO3 recovery.
31 ET reduces
distal nephron HCO3 secretion (that reduces distal nephron
acidification)23,30,43 and does so indirectly through stimu-
lated NO production.23 Other studies show that NO
stimulates overall acidification in both the proximal89 and
distal90 nephron in other settings.
POSSIBLE ET INTERACTION WITH OTHER MEDIATORS OF
KIDNEY TUBULE ACIDIFICATION
Other hormones/cytokines modify kidney tubule acidifica-
tion, but few if any have been studied to determine if and/or
how any of them interrelate with ET to modify kidney tubule
acidification. Angiotensin II (AII) stimulates luminal Naþ /
Hþ exchange and basolateral Naþ /HCO3 co-transport,
91 as
well as stimulates Hþ -ATPase92 in the proximal tubule,
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increasing acidification in this nephron segment. Whether
stimulation of Naþ /Hþ exchange by AII and ET-1 is
additive has not been reported in kidney epithelia.
Furthermore, AII stimulates distal nephron Hþ -ATPase93,94
increasing acidification in this nephron segment as
well. Because AII stimulates ET-1 secretion in kidney
mesangial cells,95 some AII effects on acidification might
be mediated through ET-1. On the other hand, cyclic
adenosine monophosphate stimulates cortical collecting
duct HCO3 secretion, thereby decreasing acidification
in this nephron segment.96 Because cyclic adenosine
monophosphate inhibits cytokine-stimulated ET-1 secre-
tion in kidney mesangial cells,97 cyclic adenosine mono-
phosphate might decrease this effect of ET to decrease
distal nephron HCO3 secretion.
23 Further studies in kidney
epithelia will be necessary to elucidate any interrelationship
between ET and these or any other factors that influence
kidney acidification.
Figure 1 outlines a proposed cascade by which ET
mediates enhanced kidney acidification in response to an
Hþ challenge.23
ROLE OF ET IN ENHANCED KIDNEY ACIDIFICATION
ASSOCIATED WITH PATHOPHYSIOLOGIC CONDITIONS
Proximal and distal nephron acidification is enhanced in
chronic metabolic alkalosis despite systemic alkalosis98 that is
mediated by increased Hþ secretion.98–100 It is reduction of
this increased distal nephron Hþ secretion (rather than an
induced increase in distal nephron HCO3 secretion) that
indeed ‘corrects’ disturbed distal nephron acidification that
characterizes the studied model of chronic metabolic
alkalosis.100 ETs mediate this physiologically inappropriate
increased (i.e., from the acid–base perspective) distal nephron
acidification in chronic metabolic alkalosis.7 Because total
body Kþ depletion is important in the maintenance of
chronic metabolic alkalosis100 and because ETs mediate
enhanced NHE type 3 activity in an autocrine manner in
proximal tubule epithelium exposed to an acid environment
in vitro,101 Kþ depletion appears to be an important
component of this effect. Indeed, Kþ repletion in chronic
alkalosis reduces the associated increased urine ET-1 excre-
tion,100 a surrogate of kidney ET-1 production,3 which is
characteristic of this disorder.7
High protein 
diet
Renal endothelin
production
???
Adrenal
endothelin
production
Distal nephron
Na+/H+ Exchange
Kidney NO
production
Distal nephron H+
secretion
Distal nephron
HCO3 secretion
NH4
+
 secretion
Urine net acid
 excretion
Aldosterone
secretion
H+-ATPase
Distal nephron
H+ secretion
Figure 1 | Proposed cascade by which high dietary protein intake increases kidney acidification through endothelins.
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The reduced functioning nephron mass of CKD challenges
remaining functioning nephrons to excrete metabolically
produced acid despite their reduced number. Animals
with CKD owing to reduced kidney mass have augmented
urine NAE per unit of remaining glomerular filtration
rate, consistent with increased nephron acidification.102
Indeed, animals with reduced kidney mass have increased
proximal103 and distal8,104,105 nephron acidification in vivo.
Animals with CKD owing to reduced kidney mass also have
increased urine ET-1 excretion,8,106 consistent with increased
endogenous kidney ET-1 production.3,8 ETs mediate en-
hanced distal nephron acidification in remnant kidneys,8 an
experimental model of CKD.
POSSIBLE ET ROLE IN COMPLICATIONS OF PATHOPHYSIO-
LOGIC CONDITIONS ASSOCIATED WITH ENHANCED KIDNEY
ACIDIFICATION
Animals with chronic metabolic alkalosis develop fibrosis
with subsequent calcium deposition in kidney parenchyma.107
In addition, experimental animals with reduced kidney mass
develop glomerulosclerosis with tubulo-interstitial fibrosis.108
ET increases kidney matrix production and fibrosis in vitro109
and might mediate glomerulosclerosis in vivo.110 Conse-
quently, increased ET activity in these and possibly other
settings might contribute to associated progressive kidney
injury through ET-mediated glomerulosclerosis and fibrosis.
Further studies will determine if there is an ET contribution
to these untoward outcomes and if ET should be a
pharmacologic target in the management of these conditions.
SUMMARY AND CONCLUSIONS
ET is a physiologic mediator of the increased acidification
that occurs in the proximal and distal nephron in response to
an acid challenge to systemic acid–base status. It mediates
increased acidification directly and indirectly, the latter by
influencing levels and/or activity of other cytokines that
themselves influence kidney acidification. The increased
kidney acidification increases Hþ excretion that helps restore
systemic acid–base status toward normal. ET appears not to
contribute to steady-state acidification in either the proximal
or distal nephron. The benefit that increased kidney ET
activity provides by mediating increased kidney Hþ excre-
tion in response to a chronic Hþ challenge might have an
untoward ‘trade off ’ if ET contributes to kidney sclerosis and
fibrosis, each of which are components of progressive kidney
disease than can reduce glomerular filtration rate.
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